Potential of selective sodium-hydrogen exchange inhibitors in cardiovascular therapy.
Scholz
W
W
Hoechst AG, SBU Cardiovascular Agents, Frankfurt/Main, Germany.
Albus
U
U
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006168:Guinea Pigs; D006863:Hydrogen-Ion Concentration; D017202:Myocardial Ischemia / Q000188:drug therapy; D015428:Myocardial Reperfusion Injury / Q000188:drug therapy; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D012964:Sodium / Q000378:metabolism; D017923:Sodium-Hydrogen Exchangers / Q000037:antagonists & inhibitors*
D017923:Sodium-Hydrogen Exchangers; D012964:Sodium; D002118:Calcium